Literature DB >> 2252041

Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: placing the elderly at risk.

R I Shorr1, S F Bauwens, C S Landefeld.   

Abstract

PURPOSE: The long-term use of benzodiazepine hypnotics by the elderly is associated with serious side effects, and prescriptions of large quantities of these agents allow such use. Therefore, we determined the quantities of these agents prescribed to outpatients in our Veterans Administration teaching hospital, and the relationship of patient age to total number of doses prescribed per prescription. PATIENTS AND METHODS: Pharmacy and patient records related to 655 consecutive prescriptions for triazolam (Halcion) and flurazepam (Dalmane) were reviewed. Only 266 (41%) of the prescriptions were for 30 or fewer doses, while 178 (27%) were written for 180 or more doses.
RESULTS: Thirty-six percent of prescriptions for patients aged 65 years or older were for 180 or more doses, compared with 24% for those aged 45 to 64 years old, and 16% of the prescriptions for patients less than 45 years old (p less than 0.0001). In a multivariate analysis controlling for six other factors related to the total number of doses prescribed, patients aged 65 years or older were still more likely to receive a prescription for 180 or more doses (relative risk 1.9, 95% confidence interval 1.3, 2.8).
CONCLUSION: We conclude that inappropriately large quantities of benzodiazepine hypnotics were commonly prescribed, and that patients aged 65 years or older were at greatest risk for receiving such prescriptions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2252041     DOI: 10.1016/0002-9343(90)90213-w

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 2.  Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors:  V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

3.  [Potentially inappropriate benzodiazepine prescriptions in elderly nursing home patients].

Authors:  R F Roberge; A Genest; J P Beauchemin; M Parent
Journal:  Can Fam Physician       Date:  1995-05       Impact factor: 3.275

4.  Questionable prescribing for elderly patients in Quebec.

Authors:  R M Tamblyn; P J McLeod; M Abrahamowicz; J Monette; D C Gayton; L Berkson; W D Dauphinee; R M Grad; A R Huang; L M Isaac
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

Review 5.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

6.  Lack of interaction between diazepam and nimodipine during chronic oral administration to healthy elderly subjects.

Authors:  P R Heine; G Weyer; H P Breuel; W Mück; N Schmage; J Kuhlmann
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

7.  Effects of zolpidem, codeine phosphate and placebo on respiration. A double-blind, crossover study in volunteers.

Authors:  M A Cohn
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

Review 8.  Rational use of benzodiazepines in the elderly.

Authors:  R I Shorr; D W Robin
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.